Bristol-Myers Squibb to Take Part in Credit Suisse 2016 Health Care Conference

11/01/2016

Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Credit Suisse Annual Health Care Conference on Tuesday, November 8, 2016 in Scottsdale, Arizona. Fouad Namouni, senior vice president, Head Oncology Development, will answer questions about the company at 8 a.m. MT (10 a.m. ET).

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedInTwitter, YouTube and Facebook.

###

Bristol-Myers Squibb CompanyMedia:Ken Dominski, 609-252-5251 ken.dominski@bms.com orInvestors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com

Multimedia Files:

Categories: Press Releases